Oncology & Cancer

Women's cancer screenings plummeted during pandemic

(HealthDay)—Breast and cervical cancer screenings dropped sharply among low-income minority women during the COVID-19 pandemic, the U.S. Centers for Disease Control and Prevention says.

Oncology & Cancer

Financial barriers to cervical cancer screening

Among low-income, uninsured, or publicly insured women ages 25-64 years who were not up to date on cervical cancer screening, 72% perceived financial barriers to screening. The most commonly reported barriers were screening ...

Oncology & Cancer

Let's talk about HPV: 6 common questions answered

Talking about a virus is all a lot of us seem to be doing at the moment. We're happy enough chatting away about COVID-19 and other common viruses like the cold or flu, so why is there so little conversation about HPV?

Vaccination

HPV vaccine shows success in gay, bisexual men

A study by Monash University and Alfred Health found a 70 percent reduction in one type of human papillomavirus (HPV) in gay and bisexual men after the implementation of the school-based HPV vaccination program.

Oncology & Cancer

HPV vaccination is lowering U.S. cervical cancer rates

In a finding that offers the first evidence that the human papillomavirus (HPV) vaccine is indeed protecting women from cervical cancer, new research shows cases in the United States have slowly but steadily declined over ...

Oncology & Cancer

Few women in sub-Saharan Africa undergo cervical cancer screenings

According to the World Health Organization, cervical cancer is the fourth most common form of cancer affecting women worldwide, and those in developing countries face a higher risk of dying from it. If detected early, cervical ...

page 23 from 40